Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial. [electronic resource]
Producer: 19961206Description: 401-16 p. digitalISSN:- 1043-0342
- ATP Binding Cassette Transporter, Subfamily B, Member 1 -- genetics
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Diseases -- chemically induced
- Breast Neoplasms -- drug therapy
- Carmustine -- administration & dosage
- Cyclophosphamide -- administration & dosage
- DNA, Complementary -- administration & dosage
- DNA, Recombinant -- administration & dosage
- Defective Viruses -- genetics
- Drug Resistance, Neoplasm -- genetics
- Ethics, Medical
- Feasibility Studies
- Female
- Granulocyte Colony-Stimulating Factor -- pharmacology
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cells -- drug effects
- Humans
- Interleukin-3 -- pharmacology
- Interleukin-6 -- pharmacology
- Mesna -- administration & dosage
- Middle Aged
- Paclitaxel -- administration & dosage
- Pilot Projects
- Recombinant Fusion Proteins -- metabolism
- Retroviridae -- genetics
- Safety
- Thiotepa -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.